Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometriosis | 36 | 2010 | 838 | 1.900 |
Why?
|
Polycystic Ovary Syndrome | 15 | 2008 | 370 | 1.280 |
Why?
|
Gonadotropin-Releasing Hormone | 22 | 2014 | 1205 | 1.250 |
Why?
|
Estradiol | 49 | 2023 | 2017 | 1.200 |
Why?
|
Leiomyoma | 21 | 2016 | 730 | 1.190 |
Why?
|
Ovulation Induction | 10 | 2012 | 274 | 1.140 |
Why?
|
Androgens | 22 | 2013 | 1247 | 1.110 |
Why?
|
Infertility, Female | 22 | 2014 | 788 | 1.090 |
Why?
|
Uterine Neoplasms | 26 | 2016 | 1513 | 1.090 |
Why?
|
Fertilization in Vitro | 20 | 2014 | 1283 | 1.080 |
Why?
|
Gynecology | 7 | 2012 | 512 | 0.960 |
Why?
|
Ovarian Follicle | 5 | 2014 | 248 | 0.830 |
Why?
|
Prolactin | 12 | 2017 | 668 | 0.810 |
Why?
|
Menstrual Cycle | 10 | 2017 | 551 | 0.770 |
Why?
|
Danazol | 17 | 1990 | 42 | 0.760 |
Why?
|
Luteinizing Hormone | 18 | 2014 | 867 | 0.760 |
Why?
|
Leuprolide | 14 | 2001 | 321 | 0.760 |
Why?
|
Gonadotropins | 5 | 2014 | 240 | 0.760 |
Why?
|
Pregnadienes | 16 | 1990 | 24 | 0.750 |
Why?
|
Follicle Stimulating Hormone | 13 | 2014 | 745 | 0.750 |
Why?
|
Fertility Agents, Female | 8 | 2014 | 99 | 0.740 |
Why?
|
Premenopause | 17 | 2017 | 1033 | 0.740 |
Why?
|
Obstetrics | 5 | 2008 | 657 | 0.580 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 5 | 1997 | 55 | 0.580 |
Why?
|
Postmenopause | 12 | 2023 | 2458 | 0.560 |
Why?
|
Gonadal Steroid Hormones | 13 | 2023 | 710 | 0.540 |
Why?
|
Pelvic Pain | 6 | 2002 | 274 | 0.540 |
Why?
|
Reproductive Techniques, Assisted | 4 | 2014 | 482 | 0.520 |
Why?
|
Metformin | 5 | 2007 | 837 | 0.520 |
Why?
|
Progesterone | 14 | 2014 | 773 | 0.510 |
Why?
|
Clomiphene | 8 | 2014 | 71 | 0.510 |
Why?
|
Genital Diseases, Female | 3 | 2010 | 197 | 0.460 |
Why?
|
Ovary | 12 | 1999 | 980 | 0.440 |
Why?
|
Testosterone | 21 | 2023 | 2297 | 0.430 |
Why?
|
Androstenedione | 15 | 2014 | 130 | 0.420 |
Why?
|
Follicular Phase | 10 | 2002 | 152 | 0.400 |
Why?
|
Reproduction | 5 | 2008 | 666 | 0.390 |
Why?
|
Infertility | 4 | 2008 | 655 | 0.390 |
Why?
|
Endometrium | 2 | 2010 | 423 | 0.380 |
Why?
|
Follicular Fluid | 2 | 2001 | 87 | 0.370 |
Why?
|
Acanthosis Nigricans | 9 | 2000 | 48 | 0.360 |
Why?
|
Estrone | 11 | 2011 | 240 | 0.360 |
Why?
|
Sex Hormone-Binding Globulin | 10 | 2023 | 546 | 0.360 |
Why?
|
Smoking | 18 | 2005 | 8984 | 0.350 |
Why?
|
Ovarian Diseases | 5 | 1993 | 139 | 0.350 |
Why?
|
Insulin | 11 | 2012 | 6584 | 0.340 |
Why?
|
Menopause | 7 | 2023 | 1626 | 0.330 |
Why?
|
Female | 188 | 2023 | 380020 | 0.320 |
Why?
|
Steroid Hydroxylases | 6 | 1989 | 96 | 0.320 |
Why?
|
Hyperandrogenism | 2 | 2000 | 38 | 0.310 |
Why?
|
Hormones | 11 | 2001 | 889 | 0.310 |
Why?
|
Chorionic Gonadotropin | 7 | 2012 | 475 | 0.300 |
Why?
|
Societies, Medical | 4 | 2008 | 3740 | 0.300 |
Why?
|
Thyrotropin | 3 | 2003 | 850 | 0.290 |
Why?
|
Estrogen Replacement Therapy | 6 | 2005 | 1203 | 0.290 |
Why?
|
Personnel Management | 1 | 2007 | 56 | 0.290 |
Why?
|
Internet | 2 | 2012 | 3058 | 0.290 |
Why?
|
Practice Management, Medical | 1 | 2008 | 196 | 0.280 |
Why?
|
Fertility | 5 | 2014 | 779 | 0.280 |
Why?
|
Glucose Tolerance Test | 4 | 2004 | 1151 | 0.270 |
Why?
|
Cotinine | 6 | 1992 | 206 | 0.270 |
Why?
|
Estrogens | 10 | 2011 | 1563 | 0.270 |
Why?
|
Theca Cells | 4 | 1994 | 15 | 0.260 |
Why?
|
Reproductive Techniques | 2 | 2005 | 41 | 0.250 |
Why?
|
Body Mass Index | 13 | 2010 | 12718 | 0.250 |
Why?
|
Granulosa Cells | 3 | 1992 | 121 | 0.250 |
Why?
|
Choriocarcinoma | 3 | 1994 | 126 | 0.250 |
Why?
|
Pyrrolidinones | 4 | 1989 | 117 | 0.250 |
Why?
|
Menorrhagia | 2 | 2002 | 63 | 0.250 |
Why?
|
Liability, Legal | 1 | 2006 | 213 | 0.240 |
Why?
|
Cervix Uteri | 2 | 1998 | 590 | 0.240 |
Why?
|
Menstruation Disturbances | 4 | 2004 | 148 | 0.240 |
Why?
|
Pregnancy | 40 | 2014 | 29140 | 0.240 |
Why?
|
Population Density | 1 | 2004 | 196 | 0.240 |
Why?
|
Advisory Committees | 1 | 2008 | 775 | 0.240 |
Why?
|
Humans | 193 | 2023 | 743811 | 0.240 |
Why?
|
Reproductive Medicine | 1 | 2005 | 108 | 0.230 |
Why?
|
Education, Medical, Continuing | 2 | 2007 | 840 | 0.230 |
Why?
|
Dehydroepiandrosterone | 9 | 2006 | 251 | 0.230 |
Why?
|
Nurses | 12 | 2014 | 2461 | 0.230 |
Why?
|
Hirsutism | 6 | 2004 | 69 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 7 | 2017 | 2017 | 0.220 |
Why?
|
Insulin Resistance | 10 | 2008 | 3863 | 0.220 |
Why?
|
Pregnancy in Adolescence | 1 | 2004 | 158 | 0.220 |
Why?
|
Abortion, Induced | 2 | 2009 | 458 | 0.220 |
Why?
|
Mycobacterium tuberculosis | 2 | 2010 | 1832 | 0.220 |
Why?
|
Hypoglycemic Agents | 4 | 2004 | 2877 | 0.210 |
Why?
|
Steroid 11-beta-Hydroxylase | 3 | 1989 | 20 | 0.210 |
Why?
|
Hysterectomy | 3 | 2016 | 927 | 0.210 |
Why?
|
Adrenal Glands | 6 | 1991 | 547 | 0.210 |
Why?
|
Adult | 101 | 2017 | 213889 | 0.210 |
Why?
|
Nicotine | 6 | 1989 | 681 | 0.210 |
Why?
|
Sterilization, Tubal | 1 | 2002 | 87 | 0.200 |
Why?
|
Herpes Genitalis | 1 | 2022 | 140 | 0.200 |
Why?
|
Dysmenorrhea | 1 | 2002 | 86 | 0.190 |
Why?
|
Ovarian Cysts | 4 | 1998 | 115 | 0.190 |
Why?
|
Tuberculosis | 2 | 2010 | 1914 | 0.190 |
Why?
|
Malpractice | 1 | 2006 | 572 | 0.190 |
Why?
|
Pregnancy Rate | 6 | 2005 | 643 | 0.190 |
Why?
|
Gonadotropins, Pituitary | 3 | 1998 | 73 | 0.190 |
Why?
|
Alcohol Drinking | 6 | 2004 | 3965 | 0.190 |
Why?
|
Embryo Transfer | 4 | 1999 | 510 | 0.190 |
Why?
|
Gamete Intrafallopian Transfer | 1 | 2000 | 27 | 0.180 |
Why?
|
Ethanol | 3 | 1996 | 1343 | 0.180 |
Why?
|
Dehydroepiandrosterone Sulfate | 7 | 2006 | 237 | 0.180 |
Why?
|
Microsomes | 8 | 1987 | 257 | 0.180 |
Why?
|
Contraceptives, Oral | 3 | 1998 | 564 | 0.180 |
Why?
|
Burnout, Professional | 1 | 2008 | 694 | 0.170 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 4 | 1996 | 68 | 0.170 |
Why?
|
Career Choice | 1 | 2005 | 743 | 0.170 |
Why?
|
Anabasine | 3 | 1987 | 6 | 0.170 |
Why?
|
Endocrinology | 3 | 2014 | 442 | 0.170 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 6 | 1994 | 140 | 0.170 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3229 | 0.170 |
Why?
|
Nafarelin | 3 | 1994 | 27 | 0.160 |
Why?
|
Ambulatory Care Facilities | 1 | 2005 | 934 | 0.160 |
Why?
|
Receptors, Progesterone | 5 | 2016 | 1098 | 0.160 |
Why?
|
Hyperinsulinism | 5 | 1994 | 414 | 0.160 |
Why?
|
Medroxyprogesterone | 3 | 1990 | 37 | 0.160 |
Why?
|
Sertoli-Leydig Cell Tumor | 1 | 1997 | 15 | 0.160 |
Why?
|
Caffeine | 2 | 2001 | 699 | 0.150 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 1999 | 188 | 0.150 |
Why?
|
Corpus Luteum | 2 | 1992 | 84 | 0.150 |
Why?
|
Fallopian Tube Diseases | 1 | 1998 | 62 | 0.150 |
Why?
|
Menstruation | 5 | 1994 | 302 | 0.150 |
Why?
|
Steroids | 7 | 2000 | 930 | 0.150 |
Why?
|
Amenorrhea | 3 | 2004 | 485 | 0.150 |
Why?
|
Pituitary Gland | 2 | 1999 | 664 | 0.150 |
Why?
|
Endometrial Neoplasms | 3 | 2010 | 1350 | 0.150 |
Why?
|
Leydig Cells | 5 | 1992 | 56 | 0.140 |
Why?
|
Nucleolus Organizer Region | 2 | 1993 | 26 | 0.140 |
Why?
|
Hormone Antagonists | 1 | 1997 | 108 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 971 | 0.140 |
Why?
|
Norpregnadienes | 1 | 2016 | 3 | 0.140 |
Why?
|
Internship and Residency | 3 | 2008 | 5787 | 0.140 |
Why?
|
Somatomedins | 4 | 2005 | 192 | 0.140 |
Why?
|
Pregnancy in Diabetics | 3 | 1986 | 179 | 0.140 |
Why?
|
Estrogen Antagonists | 2 | 1998 | 151 | 0.140 |
Why?
|
Infertility, Male | 3 | 2010 | 404 | 0.140 |
Why?
|
Testis | 6 | 1989 | 795 | 0.140 |
Why?
|
Contraceptives, Oral, Combined | 1 | 1997 | 113 | 0.140 |
Why?
|
Aging | 3 | 2012 | 8655 | 0.140 |
Why?
|
Referral and Consultation | 3 | 2009 | 3530 | 0.130 |
Why?
|
Breast Neoplasms | 13 | 2013 | 20827 | 0.130 |
Why?
|
Mediator Complex | 1 | 2016 | 109 | 0.130 |
Why?
|
Dietary Fats | 3 | 2010 | 2016 | 0.130 |
Why?
|
Syndrome | 9 | 2000 | 3249 | 0.130 |
Why?
|
Ovulation | 6 | 2002 | 189 | 0.130 |
Why?
|
Analgesics, Non-Narcotic | 1 | 1998 | 366 | 0.130 |
Why?
|
Aromatase | 3 | 1986 | 147 | 0.130 |
Why?
|
Parity | 6 | 2014 | 929 | 0.120 |
Why?
|
Steroid 21-Hydroxylase | 2 | 1987 | 34 | 0.120 |
Why?
|
Writing | 1 | 1996 | 206 | 0.120 |
Why?
|
Ethinyl Estradiol | 3 | 1997 | 116 | 0.120 |
Why?
|
Acetaminophen | 1 | 1998 | 545 | 0.120 |
Why?
|
Antigens, Neoplasm | 3 | 1987 | 1988 | 0.120 |
Why?
|
Birth Weight | 3 | 2008 | 2069 | 0.120 |
Why?
|
Menopause, Premature | 1 | 1995 | 132 | 0.120 |
Why?
|
Diabetes, Gestational | 2 | 2004 | 1184 | 0.120 |
Why?
|
Ovarian Hyperstimulation Syndrome | 1 | 1994 | 53 | 0.120 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 1997 | 413 | 0.120 |
Why?
|
Endometritis | 2 | 2010 | 48 | 0.120 |
Why?
|
Sports | 4 | 1995 | 688 | 0.110 |
Why?
|
Administration, Cutaneous | 4 | 1998 | 710 | 0.110 |
Why?
|
Pregnancy Outcome | 3 | 2000 | 2794 | 0.110 |
Why?
|
Isoenzymes | 1 | 1997 | 1728 | 0.110 |
Why?
|
Dihydrotestosterone | 6 | 1994 | 185 | 0.100 |
Why?
|
Research Support as Topic | 1 | 1996 | 705 | 0.100 |
Why?
|
Oocytes | 2 | 2012 | 1186 | 0.100 |
Why?
|
Ovarian Neoplasms | 5 | 2010 | 4839 | 0.100 |
Why?
|
Radiology, Interventional | 1 | 2016 | 460 | 0.100 |
Why?
|
Tamoxifen | 2 | 1995 | 981 | 0.100 |
Why?
|
Leptin | 1 | 2000 | 1600 | 0.100 |
Why?
|
Laparoscopy | 3 | 2004 | 2148 | 0.100 |
Why?
|
Educational Status | 1 | 1999 | 2540 | 0.100 |
Why?
|
Granuloma | 2 | 2010 | 319 | 0.100 |
Why?
|
Buserelin | 1 | 1990 | 17 | 0.100 |
Why?
|
Menotropins | 3 | 1990 | 45 | 0.100 |
Why?
|
Middle Aged | 52 | 2023 | 213241 | 0.100 |
Why?
|
Diethylstilbestrol | 2 | 2004 | 92 | 0.100 |
Why?
|
RNA, Messenger | 3 | 1997 | 13028 | 0.090 |
Why?
|
Growth Hormone | 2 | 1991 | 705 | 0.090 |
Why?
|
Oligomenorrhea | 1 | 1990 | 45 | 0.090 |
Why?
|
Amniotic Fluid | 4 | 1994 | 370 | 0.090 |
Why?
|
Gestrinone | 1 | 1990 | 2 | 0.090 |
Why?
|
Norpregnatrienes | 1 | 1990 | 2 | 0.090 |
Why?
|
Body Composition | 3 | 1995 | 2401 | 0.090 |
Why?
|
Guanine | 1 | 2011 | 274 | 0.090 |
Why?
|
Glutamates | 1 | 2011 | 397 | 0.090 |
Why?
|
Medical Records | 1 | 1995 | 1412 | 0.090 |
Why?
|
Molecular Biology | 1 | 2014 | 595 | 0.090 |
Why?
|
Epitopes | 2 | 1987 | 2570 | 0.090 |
Why?
|
Adipose Tissue | 4 | 1995 | 3280 | 0.090 |
Why?
|
Fallopian Tubes | 1 | 2010 | 182 | 0.090 |
Why?
|
Myometrium | 3 | 1995 | 181 | 0.090 |
Why?
|
Placebos | 4 | 2004 | 1674 | 0.090 |
Why?
|
Delivery of Health Care | 2 | 2007 | 5319 | 0.080 |
Why?
|
Drug Therapy, Combination | 5 | 2004 | 6487 | 0.080 |
Why?
|
Hydrocortisone | 5 | 1992 | 1826 | 0.080 |
Why?
|
Pituitary Hormone-Releasing Hormones | 1 | 1988 | 41 | 0.080 |
Why?
|
Piperidines | 2 | 1987 | 1601 | 0.080 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1990 | 272 | 0.080 |
Why?
|
Pregnancy, Multiple | 2 | 2004 | 217 | 0.080 |
Why?
|
Norethindrone | 2 | 1990 | 59 | 0.080 |
Why?
|
Dietary Fiber | 2 | 2000 | 759 | 0.080 |
Why?
|
Prospective Studies | 22 | 2010 | 53250 | 0.080 |
Why?
|
Endocrine Glands | 2 | 1990 | 103 | 0.080 |
Why?
|
Reference Values | 6 | 2000 | 4974 | 0.080 |
Why?
|
Receptors, Estrogen | 4 | 2004 | 2190 | 0.080 |
Why?
|
Research | 1 | 1996 | 1999 | 0.080 |
Why?
|
Ovariectomy | 3 | 1998 | 661 | 0.080 |
Why?
|
Fasting | 4 | 1999 | 1590 | 0.070 |
Why?
|
Receptors, Steroid | 3 | 1990 | 155 | 0.070 |
Why?
|
Cross-Over Studies | 4 | 1996 | 2029 | 0.070 |
Why?
|
Risk Factors | 24 | 2013 | 72252 | 0.070 |
Why?
|
United States | 16 | 2014 | 69859 | 0.070 |
Why?
|
Steroid 17-alpha-Hydroxylase | 3 | 1981 | 98 | 0.070 |
Why?
|
Hair Color | 1 | 2006 | 136 | 0.070 |
Why?
|
Half-Life | 2 | 1998 | 660 | 0.070 |
Why?
|
Connexin 43 | 3 | 1995 | 207 | 0.070 |
Why?
|
Antitubercular Agents | 2 | 2010 | 1320 | 0.060 |
Why?
|
Case-Control Studies | 13 | 2013 | 21733 | 0.060 |
Why?
|
Placenta | 3 | 1986 | 1699 | 0.060 |
Why?
|
Medical Informatics | 1 | 2012 | 745 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 3 | 2017 | 424 | 0.060 |
Why?
|
Uterus | 4 | 1997 | 711 | 0.060 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1985 | 147 | 0.060 |
Why?
|
Life Style | 3 | 2010 | 3833 | 0.060 |
Why?
|
Insurance, Liability | 1 | 2005 | 102 | 0.060 |
Why?
|
Diabetes Insipidus | 1 | 1985 | 151 | 0.060 |
Why?
|
Organizational Objectives | 1 | 2007 | 438 | 0.060 |
Why?
|
Trophoblasts | 1 | 1986 | 215 | 0.060 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2004 | 54 | 0.060 |
Why?
|
Chronic Disease | 5 | 2002 | 9139 | 0.060 |
Why?
|
Contraception | 1 | 2008 | 359 | 0.060 |
Why?
|
Salvage Therapy | 1 | 2011 | 1275 | 0.060 |
Why?
|
Biopsy | 3 | 2010 | 6750 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.060 |
Why?
|
Kinetics | 7 | 1989 | 6476 | 0.060 |
Why?
|
Exercise | 5 | 2007 | 5611 | 0.060 |
Why?
|
Hydroxysteroid Dehydrogenases | 2 | 1981 | 29 | 0.060 |
Why?
|
Time Factors | 12 | 2002 | 40038 | 0.060 |
Why?
|
Receptor, Insulin | 3 | 1994 | 846 | 0.060 |
Why?
|
Cytochrome P-450 Enzyme System | 5 | 1989 | 419 | 0.060 |
Why?
|
Massachusetts | 3 | 2006 | 8660 | 0.060 |
Why?
|
Subcellular Fractions | 4 | 1992 | 545 | 0.060 |
Why?
|
Body Size | 1 | 2006 | 461 | 0.060 |
Why?
|
Pituitary Diseases | 1 | 1985 | 140 | 0.060 |
Why?
|
Hypothalamic Diseases | 1 | 1985 | 135 | 0.060 |
Why?
|
Age Distribution | 3 | 2005 | 2899 | 0.060 |
Why?
|
Fetal Blood | 3 | 1994 | 1318 | 0.060 |
Why?
|
Hypopituitarism | 1 | 1985 | 254 | 0.060 |
Why?
|
Bromocriptine | 1 | 1983 | 111 | 0.060 |
Why?
|
Clinical Trials as Topic | 5 | 2004 | 7908 | 0.060 |
Why?
|
Luteal Phase | 4 | 1999 | 147 | 0.060 |
Why?
|
Peptide Fragments | 2 | 1986 | 5096 | 0.060 |
Why?
|
Managed Care Programs | 2 | 2000 | 950 | 0.060 |
Why?
|
Decision Support Systems, Clinical | 1 | 2012 | 1164 | 0.060 |
Why?
|
Pain | 1 | 1998 | 4987 | 0.060 |
Why?
|
Intra-Abdominal Fat | 1 | 2008 | 591 | 0.060 |
Why?
|
Body Constitution | 2 | 2004 | 278 | 0.050 |
Why?
|
Aromatase Inhibitors | 1 | 1986 | 487 | 0.050 |
Why?
|
Adolescent Health Services | 1 | 2004 | 215 | 0.050 |
Why?
|
CA-125 Antigen | 2 | 2002 | 286 | 0.050 |
Why?
|
Sperm Motility | 1 | 2003 | 251 | 0.050 |
Why?
|
Multivariate Analysis | 5 | 2011 | 12243 | 0.050 |
Why?
|
Income | 2 | 2014 | 1913 | 0.050 |
Why?
|
Logistic Models | 7 | 2011 | 13404 | 0.050 |
Why?
|
Antigens, Surface | 1 | 1986 | 1663 | 0.050 |
Why?
|
Cross-Sectional Studies | 9 | 2010 | 25032 | 0.050 |
Why?
|
Genital Neoplasms, Female | 1 | 1987 | 523 | 0.050 |
Why?
|
Progestins | 3 | 1995 | 306 | 0.050 |
Why?
|
Oxidoreductases | 2 | 1981 | 424 | 0.050 |
Why?
|
Angioedema | 1 | 1983 | 187 | 0.050 |
Why?
|
Patient Selection | 3 | 2010 | 4210 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2022 | 189 | 0.050 |
Why?
|
Urinary Incontinence | 1 | 2005 | 496 | 0.050 |
Why?
|
Obesity | 4 | 2008 | 12744 | 0.050 |
Why?
|
Megestrol | 1 | 1980 | 8 | 0.050 |
Why?
|
Risk | 6 | 2010 | 9677 | 0.050 |
Why?
|
Catechols | 1 | 1980 | 61 | 0.050 |
Why?
|
Linear Models | 3 | 2010 | 5952 | 0.050 |
Why?
|
Castration | 3 | 2011 | 158 | 0.050 |
Why?
|
Drinking | 1 | 2001 | 197 | 0.050 |
Why?
|
Rats | 13 | 1989 | 24250 | 0.050 |
Why?
|
Capitation Fee | 1 | 2000 | 116 | 0.050 |
Why?
|
Women's Health Services | 1 | 2000 | 93 | 0.050 |
Why?
|
Antineoplastic Agents | 4 | 2011 | 13691 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 1990 | 703 | 0.040 |
Why?
|
Male | 33 | 2011 | 349776 | 0.040 |
Why?
|
Pregnancy, High-Risk | 1 | 2000 | 120 | 0.040 |
Why?
|
Anthropometry | 1 | 2004 | 1348 | 0.040 |
Why?
|
Mixed Function Oxygenases | 3 | 1992 | 271 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2001 | 4931 | 0.040 |
Why?
|
Hyperglycemia | 1 | 2008 | 1373 | 0.040 |
Why?
|
Cohort Studies | 10 | 2007 | 40545 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1995 | 8430 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2008 | 1077 | 0.040 |
Why?
|
Substrate Specificity | 3 | 1992 | 1802 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2001 | 10940 | 0.040 |
Why?
|
Drug Interactions | 2 | 1994 | 1460 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6188 | 0.040 |
Why?
|
Medroxyprogesterone Acetate | 4 | 1996 | 163 | 0.040 |
Why?
|
Oogenesis | 1 | 1999 | 132 | 0.040 |
Why?
|
Rabbits | 2 | 2002 | 4894 | 0.040 |
Why?
|
Rats, Inbred Strains | 3 | 1989 | 2184 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2022 | 1159 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2004 | 2407 | 0.040 |
Why?
|
Mutation | 5 | 1996 | 29777 | 0.040 |
Why?
|
Communication | 1 | 2012 | 3748 | 0.040 |
Why?
|
Chromosome Aberrations | 2 | 1998 | 1811 | 0.040 |
Why?
|
Ligaments | 1 | 1998 | 129 | 0.040 |
Why?
|
Human Growth Hormone | 2 | 2017 | 684 | 0.040 |
Why?
|
Body Weight | 6 | 2000 | 4670 | 0.040 |
Why?
|
Respiratory Distress Syndrome, Newborn | 2 | 1992 | 214 | 0.040 |
Why?
|
Tumor Cells, Cultured | 3 | 1995 | 6311 | 0.040 |
Why?
|
Collagen | 3 | 1995 | 2681 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 3921 | 0.040 |
Why?
|
Pregnancy Complications | 3 | 1998 | 2861 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2005 | 15067 | 0.040 |
Why?
|
Estradiol Congeners | 1 | 1997 | 28 | 0.040 |
Why?
|
Norgestrel | 1 | 1997 | 11 | 0.040 |
Why?
|
Basal Metabolism | 1 | 1998 | 168 | 0.040 |
Why?
|
Progesterone Congeners | 1 | 1997 | 42 | 0.040 |
Why?
|
Receptors, Glucocorticoid | 1 | 1979 | 302 | 0.040 |
Why?
|
Maternal Age | 1 | 2000 | 802 | 0.040 |
Why?
|
Coffee | 1 | 2001 | 576 | 0.040 |
Why?
|
Motor Activity | 1 | 2007 | 2714 | 0.040 |
Why?
|
Animals | 20 | 2002 | 168660 | 0.040 |
Why?
|
Contraceptives, Postcoital, Synthetic | 1 | 1996 | 3 | 0.040 |
Why?
|
Stimulation, Chemical | 3 | 1989 | 326 | 0.040 |
Why?
|
Proportional Hazards Models | 4 | 2010 | 12354 | 0.030 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1998 | 275 | 0.030 |
Why?
|
Abdominal Abscess | 1 | 1998 | 154 | 0.030 |
Why?
|
Tissue Distribution | 2 | 1992 | 2327 | 0.030 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 2 | 1986 | 73 | 0.030 |
Why?
|
HIV Infections | 1 | 2022 | 16715 | 0.030 |
Why?
|
Pelvic Inflammatory Disease | 2 | 1986 | 94 | 0.030 |
Why?
|
Random Allocation | 4 | 1995 | 2429 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2012 | 4467 | 0.030 |
Why?
|
Hyperplasia | 2 | 1991 | 1185 | 0.030 |
Why?
|
Models, Biological | 1 | 1992 | 9582 | 0.030 |
Why?
|
Calcium | 3 | 1995 | 5755 | 0.030 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 1996 | 98 | 0.030 |
Why?
|
Blood Glucose | 3 | 1999 | 6259 | 0.030 |
Why?
|
Age Factors | 5 | 2014 | 18355 | 0.030 |
Why?
|
Pedigree | 2 | 1994 | 4643 | 0.030 |
Why?
|
Mullerian Ducts | 1 | 1996 | 198 | 0.030 |
Why?
|
Confidence Intervals | 3 | 2006 | 2971 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 2 | 1989 | 91 | 0.030 |
Why?
|
Retreatment | 1 | 1997 | 609 | 0.030 |
Why?
|
Periodicals as Topic | 1 | 1986 | 1429 | 0.030 |
Why?
|
17-Ketosteroids | 2 | 1996 | 39 | 0.030 |
Why?
|
Testolactone | 1 | 1994 | 7 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2007 | 3187 | 0.030 |
Why?
|
Incidence | 7 | 2010 | 20948 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 1998 | 1108 | 0.030 |
Why?
|
Hypothyroidism | 1 | 1980 | 659 | 0.030 |
Why?
|
Administration, Intranasal | 2 | 1994 | 446 | 0.030 |
Why?
|
Intermediate Filament Proteins | 1 | 1995 | 269 | 0.030 |
Why?
|
Receptors, Growth Factor | 1 | 1995 | 334 | 0.030 |
Why?
|
Double-Blind Method | 6 | 1996 | 12020 | 0.030 |
Why?
|
Analysis of Variance | 4 | 2002 | 6356 | 0.030 |
Why?
|
Insemination, Artificial | 1 | 2014 | 98 | 0.030 |
Why?
|
Pelvis | 1 | 1998 | 730 | 0.030 |
Why?
|
Cesarean Section | 1 | 2002 | 1365 | 0.030 |
Why?
|
Binding, Competitive | 2 | 1987 | 1157 | 0.030 |
Why?
|
Growth Substances | 1 | 1995 | 784 | 0.030 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2000 | 948 | 0.030 |
Why?
|
Drug Utilization Review | 1 | 2014 | 245 | 0.030 |
Why?
|
Thiazoles | 1 | 2000 | 1482 | 0.030 |
Why?
|
Thromboembolism | 1 | 1999 | 987 | 0.030 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 1992 | 34 | 0.030 |
Why?
|
Cicatrix | 1 | 1998 | 763 | 0.030 |
Why?
|
Torsion Abnormality | 1 | 1993 | 93 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3208 | 0.030 |
Why?
|
Potassium Channels | 1 | 1995 | 563 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2013 | 916 | 0.030 |
Why?
|
Weight Loss | 1 | 2004 | 2625 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 2 | 1993 | 648 | 0.030 |
Why?
|
Delayed-Action Preparations | 2 | 1993 | 967 | 0.030 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1994 | 369 | 0.030 |
Why?
|
Estriol | 1 | 2011 | 53 | 0.030 |
Why?
|
Glutathione Transferase | 1 | 1994 | 595 | 0.030 |
Why?
|
Cortodoxone | 2 | 1989 | 13 | 0.030 |
Why?
|
Uterine Hemorrhage | 1 | 1994 | 255 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1994 | 1581 | 0.030 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1994 | 491 | 0.030 |
Why?
|
Methods | 1 | 1992 | 1128 | 0.030 |
Why?
|
Codon | 1 | 1994 | 611 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 1998 | 1702 | 0.030 |
Why?
|
Thrombocytosis | 1 | 1992 | 81 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 1993 | 235 | 0.030 |
Why?
|
Risk Assessment | 6 | 2011 | 23327 | 0.030 |
Why?
|
Nutritional Physiological Phenomena | 2 | 1990 | 370 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8637 | 0.020 |
Why?
|
History, 17th Century | 1 | 2011 | 111 | 0.020 |
Why?
|
Molecular Weight | 1 | 1994 | 2253 | 0.020 |
Why?
|
Financing, Personal | 1 | 2014 | 308 | 0.020 |
Why?
|
Lactation | 2 | 2004 | 411 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 1995 | 35409 | 0.020 |
Why?
|
Genes, Recessive | 1 | 1994 | 641 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3510 | 0.020 |
Why?
|
Anovulation | 1 | 1991 | 58 | 0.020 |
Why?
|
Genitalia, Female | 1 | 1992 | 146 | 0.020 |
Why?
|
Remission Induction | 1 | 1997 | 2384 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2013 | 39001 | 0.020 |
Why?
|
Adolescent | 4 | 2004 | 85729 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2005 | 11729 | 0.020 |
Why?
|
Hydroxyestrones | 2 | 1999 | 17 | 0.020 |
Why?
|
Adrenal Cortex | 1 | 1991 | 140 | 0.020 |
Why?
|
Prevalence | 1 | 2007 | 15211 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 2961 | 0.020 |
Why?
|
Evaluation Studies as Topic | 3 | 1991 | 1677 | 0.020 |
Why?
|
Nutrition Disorders | 1 | 1991 | 211 | 0.020 |
Why?
|
Goserelin | 1 | 1990 | 129 | 0.020 |
Why?
|
Physicians | 1 | 2008 | 4569 | 0.020 |
Why?
|
Pelvic Neoplasms | 1 | 1992 | 254 | 0.020 |
Why?
|
Lyases | 2 | 1981 | 41 | 0.020 |
Why?
|
Menarche | 2 | 2004 | 516 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2006 | 2883 | 0.020 |
Why?
|
Swine | 2 | 1994 | 5909 | 0.020 |
Why?
|
Scoliosis | 1 | 1996 | 725 | 0.020 |
Why?
|
Diet | 1 | 2007 | 7930 | 0.020 |
Why?
|
Analgesia | 1 | 1994 | 461 | 0.020 |
Why?
|
Physical Education and Training | 1 | 1989 | 106 | 0.020 |
Why?
|
Blood Preservation | 1 | 1989 | 177 | 0.020 |
Why?
|
Bone Density | 2 | 1992 | 3460 | 0.020 |
Why?
|
Spectrophotometry | 2 | 1980 | 313 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11059 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2002 | 11360 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1999 | 2707 | 0.020 |
Why?
|
Transportation | 1 | 1989 | 214 | 0.020 |
Why?
|
Fetus | 2 | 1989 | 1880 | 0.020 |
Why?
|
Treatment Outcome | 3 | 1999 | 63042 | 0.020 |
Why?
|
Taxoids | 1 | 2011 | 666 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2011 | 975 | 0.020 |
Why?
|
Health Surveys | 2 | 2010 | 4036 | 0.020 |
Why?
|
Catechol O-Methyltransferase | 2 | 1980 | 245 | 0.020 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 1987 | 22 | 0.020 |
Why?
|
Women | 1 | 1989 | 230 | 0.020 |
Why?
|
Causality | 1 | 1994 | 1275 | 0.020 |
Why?
|
Hydroxyprogesterones | 1 | 1987 | 25 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1894 | 0.020 |
Why?
|
Nucleotidyltransferases | 1 | 1989 | 220 | 0.020 |
Why?
|
Cost of Illness | 1 | 1997 | 1859 | 0.020 |
Why?
|
Reoperation | 1 | 1997 | 4200 | 0.020 |
Why?
|
Observer Variation | 1 | 1993 | 2592 | 0.020 |
Why?
|
Decamethonium Compounds | 1 | 1986 | 7 | 0.020 |
Why?
|
Hexamethonium Compounds | 1 | 1986 | 23 | 0.020 |
Why?
|
Thyroxine | 3 | 1995 | 667 | 0.020 |
Why?
|
Luteal Cells | 1 | 1986 | 19 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2010 | 723 | 0.020 |
Why?
|
Demography | 2 | 2004 | 1653 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2453 | 0.020 |
Why?
|
Ascitic Fluid | 1 | 1987 | 192 | 0.020 |
Why?
|
Succinylcholine | 1 | 1986 | 67 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 1999 | 14714 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2006 | 19894 | 0.020 |
Why?
|
Carbachol | 1 | 1986 | 226 | 0.020 |
Why?
|
Blotting, Western | 1 | 1994 | 5179 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1992 | 1459 | 0.020 |
Why?
|
Drug Costs | 1 | 1993 | 1105 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1994 | 3772 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1156 | 0.020 |
Why?
|
Pituitary Function Tests | 1 | 1985 | 27 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2006 | 516 | 0.020 |
Why?
|
Pituitary Neoplasms | 2 | 1985 | 1345 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2013 | 11036 | 0.020 |
Why?
|
Phosphatidylcholines | 3 | 1994 | 410 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1986 | 719 | 0.020 |
Why?
|
Aged | 12 | 2011 | 163178 | 0.020 |
Why?
|
Specimen Handling | 1 | 1989 | 694 | 0.020 |
Why?
|
Recurrence | 1 | 1997 | 8337 | 0.020 |
Why?
|
Regression Analysis | 3 | 2005 | 6457 | 0.020 |
Why?
|
Retrospective Studies | 4 | 1998 | 77410 | 0.020 |
Why?
|
Borohydrides | 1 | 1983 | 32 | 0.010 |
Why?
|
Virilism | 1 | 1983 | 31 | 0.010 |
Why?
|
Dopamine Antagonists | 1 | 1985 | 296 | 0.010 |
Why?
|
Women's Health | 1 | 2013 | 2033 | 0.010 |
Why?
|
Vitamins | 1 | 1992 | 1622 | 0.010 |
Why?
|
Temperature | 1 | 1989 | 2202 | 0.010 |
Why?
|
Infant, Newborn | 5 | 2000 | 25609 | 0.010 |
Why?
|
Cells, Cultured | 3 | 1993 | 19232 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2002 | 18027 | 0.010 |
Why?
|
Lung | 3 | 1994 | 9858 | 0.010 |
Why?
|
Phosphorylation | 1 | 1994 | 8436 | 0.010 |
Why?
|
Base Sequence | 1 | 1994 | 12798 | 0.010 |
Why?
|
Karyotyping | 2 | 1998 | 1243 | 0.010 |
Why?
|
Odds Ratio | 2 | 2006 | 9848 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2014 | 1900 | 0.010 |
Why?
|
Androgen Antagonists | 1 | 2011 | 1376 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 1995 | 5388 | 0.010 |
Why?
|
Gestational Age | 2 | 1994 | 3488 | 0.010 |
Why?
|
NADP | 1 | 1983 | 226 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1999 | 9944 | 0.010 |
Why?
|
Immunoassay | 1 | 1986 | 751 | 0.010 |
Why?
|
Pseudopregnancy | 1 | 1981 | 11 | 0.010 |
Why?
|
Chromosome Disorders | 2 | 1998 | 510 | 0.010 |
Why?
|
Escherichia coli | 1 | 1994 | 4216 | 0.010 |
Why?
|
Menstrual Hygiene Products | 1 | 1981 | 18 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2942 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2011 | 2471 | 0.010 |
Why?
|
Preoperative Care | 1 | 1990 | 2251 | 0.010 |
Why?
|
Thyroid Diseases | 1 | 1985 | 379 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 1981 | 380 | 0.010 |
Why?
|
Sex Factors | 2 | 1985 | 10394 | 0.010 |
Why?
|
Estrogens, Catechol | 1 | 1980 | 25 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 18107 | 0.010 |
Why?
|
Bone and Bones | 1 | 1992 | 2576 | 0.010 |
Why?
|
Mitochondria | 2 | 1987 | 3513 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7719 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6539 | 0.010 |
Why?
|
Models, Statistical | 1 | 1995 | 5100 | 0.010 |
Why?
|
Thyroxine-Binding Proteins | 1 | 1980 | 25 | 0.010 |
Why?
|
Cats | 1 | 1981 | 986 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1998 | 5264 | 0.010 |
Why?
|
Fetal Organ Maturity | 2 | 1992 | 82 | 0.010 |
Why?
|
Mestranol | 1 | 1979 | 9 | 0.010 |
Why?
|
Methyltestosterone | 1 | 1979 | 19 | 0.010 |
Why?
|
Triiodothyronine | 2 | 1995 | 494 | 0.010 |
Why?
|
Reproductive History | 1 | 2000 | 209 | 0.010 |
Why?
|
Sphingomyelins | 2 | 1992 | 106 | 0.010 |
Why?
|
Heterozygote | 2 | 2000 | 2803 | 0.010 |
Why?
|
Drug Synergism | 1 | 1983 | 1794 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2005 | 2369 | 0.010 |
Why?
|
Spectrum Analysis | 1 | 1981 | 454 | 0.010 |
Why?
|
Microsomes, Liver | 1 | 1978 | 174 | 0.010 |
Why?
|
Abortion, Legal | 1 | 1980 | 116 | 0.010 |
Why?
|
Phenobarbital | 1 | 1978 | 193 | 0.010 |
Why?
|
Edema | 1 | 1982 | 789 | 0.010 |
Why?
|
Biological Availability | 1 | 1998 | 397 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1980 | 694 | 0.010 |
Why?
|
Pilot Projects | 1 | 1990 | 8316 | 0.010 |
Why?
|
Sperm Count | 1 | 1998 | 215 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1989 | 1877 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1986 | 6380 | 0.010 |
Why?
|
Abortion, Spontaneous | 1 | 1982 | 544 | 0.010 |
Why?
|
Risk Adjustment | 1 | 2000 | 594 | 0.010 |
Why?
|
17-Hydroxycorticosteroids | 1 | 1996 | 40 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5170 | 0.010 |
Why?
|
Dopamine | 1 | 1983 | 1592 | 0.010 |
Why?
|
Body Height | 2 | 1993 | 1579 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1993 | 15526 | 0.010 |
Why?
|
Dietary Proteins | 1 | 2000 | 962 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1990 | 4245 | 0.010 |
Why?
|
Prognosis | 2 | 2013 | 29052 | 0.010 |
Why?
|
Shock, Septic | 1 | 1981 | 775 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1981 | 1173 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1991 | 8939 | 0.010 |
Why?
|
Adenoma | 1 | 1985 | 2173 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 1995 | 331 | 0.010 |
Why?
|
Cricetinae | 1 | 1977 | 2475 | 0.010 |
Why?
|
Gene Frequency | 1 | 2000 | 3585 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1994 | 11708 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1991 | 6363 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 1995 | 390 | 0.010 |
Why?
|
Energy Intake | 1 | 2000 | 2149 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1981 | 1400 | 0.010 |
Why?
|
Gap Junctions | 1 | 1993 | 233 | 0.010 |
Why?
|
Hydroxylation | 1 | 1992 | 141 | 0.010 |
Why?
|
Deuterium Oxide | 1 | 1991 | 34 | 0.010 |
Why?
|
Oxygen | 1 | 1983 | 4189 | 0.010 |
Why?
|
Deuterium | 1 | 1991 | 101 | 0.010 |
Why?
|
Ultrasonography | 2 | 1998 | 5986 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 1994 | 571 | 0.010 |
Why?
|
Quadruplets | 1 | 1990 | 9 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1992 | 683 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1981 | 3794 | 0.010 |
Why?
|
Triplets | 1 | 1990 | 43 | 0.010 |
Why?
|
Body Water | 1 | 1991 | 343 | 0.010 |
Why?
|
Pregnanediol | 1 | 1989 | 18 | 0.010 |
Why?
|
Nitrogen | 1 | 1991 | 344 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 1994 | 1364 | 0.010 |
Why?
|
Mitosis | 1 | 1995 | 1207 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1993 | 934 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2005 | 13980 | 0.010 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1994 | 500 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1985 | 12954 | 0.010 |
Why?
|
Cholesterol | 2 | 1989 | 2922 | 0.010 |
Why?
|
Lactose | 1 | 1989 | 95 | 0.010 |
Why?
|
Platelet Count | 1 | 1992 | 780 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1987 | 10179 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1986 | 9272 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1758 | 0.000 |
Why?
|
Galactosemias | 1 | 1989 | 125 | 0.000 |
Why?
|
Phytohemagglutinins | 1 | 1987 | 170 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1995 | 2123 | 0.000 |
Why?
|
Amino Acids | 1 | 1993 | 1733 | 0.000 |
Why?
|
Population Surveillance | 1 | 1997 | 2614 | 0.000 |
Why?
|
Cervical Vertebrae | 1 | 1993 | 976 | 0.000 |
Why?
|
Transfection | 1 | 1995 | 5892 | 0.000 |
Why?
|
Adrenal Cortex Hormones | 1 | 1996 | 1854 | 0.000 |
Why?
|
Physical Fitness | 1 | 1991 | 732 | 0.000 |
Why?
|
Carotenoids | 1 | 1989 | 623 | 0.000 |
Why?
|
Self Administration | 1 | 1987 | 386 | 0.000 |
Why?
|
Injections, Subcutaneous | 1 | 1987 | 667 | 0.000 |
Why?
|
Culture Media | 1 | 1987 | 909 | 0.000 |
Why?
|
Vitamin E | 1 | 1989 | 868 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6620 | 0.000 |
Why?
|
Genetic Variation | 1 | 2000 | 6535 | 0.000 |
Why?
|
Water | 1 | 1991 | 1394 | 0.000 |
Why?
|
ROC Curve | 1 | 1992 | 3527 | 0.000 |
Why?
|
Lumbar Vertebrae | 1 | 1993 | 1848 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1994 | 4326 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1989 | 2183 | 0.000 |
Why?
|
Aged, 80 and over | 3 | 1994 | 57744 | 0.000 |
Why?
|
Kidney | 1 | 1978 | 7185 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1991 | 5078 | 0.000 |
Why?
|
17-alpha-Hydroxypregnenolone | 1 | 1980 | 5 | 0.000 |
Why?
|
Pregnenolone | 1 | 1980 | 26 | 0.000 |
Why?
|
Cell Division | 1 | 1987 | 4568 | 0.000 |
Why?
|
Mice | 1 | 1986 | 81154 | 0.000 |
Why?
|
Lipids | 1 | 1989 | 3307 | 0.000 |
Why?
|
Monocytes | 1 | 1987 | 2593 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1987 | 5524 | 0.000 |
Why?
|
DNA | 1 | 1989 | 7295 | 0.000 |
Why?
|
Genotype | 1 | 1989 | 12944 | 0.000 |
Why?
|
Hypertension | 1 | 1994 | 8480 | 0.000 |
Why?
|
Brain | 1 | 1978 | 26345 | 0.000 |
Why?
|
Child | 1 | 1977 | 77637 | 0.000 |
Why?
|